GC
HZNP

Gratus Capital’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Gratus Capital’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-6,579
Closed -$761K – 275
2023
Q3 		$761K Buy
6,579
+320
+5% +$34.4K 0.05% 149
2023
Q2 		$644K Sell
6,259
-59
-0.9% -$6.22K 0.04% 160
2023
Q1 		$690K Buy
+6,318
New +$698K 0.05% 144

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Gratus Capital's HZNP Position: Q4 2023 in Review

Gratus Capital sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 6,579 shares — an estimated $761K sold.

Gratus Capital first reported a position in HZNP in Q1 2023 and held it in 3 quarters. The position peaked at $761K in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Gratus Capital reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Gratus Capital sold 6,579 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $761K.
  • Gratus Capital first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023 and held it in 3 quarters.
  • Gratus Capital's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $761K in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Gratus Capital's 13F filing for Q4 2023, filed 7 Feb 2024.